Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.

Gavini E, Rassu G, Ferraro L, Beggiato S, Alhalaweh A, Velaga S, Marchetti N, Bandiera P, Giunchedi P, Dalpiaz A.

Eur J Pharm Biopharm. 2013 Feb;83(2):174-83. doi: 10.1016/j.ejpb.2012.10.010. Epub 2012 Nov 12.

PMID:
23153670
2.

Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.

Abdou EM, Kandil SM, Miniawy HMFE.

Int J Pharm. 2017 Aug 30;529(1-2):667-677. doi: 10.1016/j.ijpharm.2017.07.030. Epub 2017 Jul 17.

PMID:
28729175
3.

Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.

Abd-Elal RM, Shamma RN, Rashed HM, Bendas ER.

Drug Deliv. 2016 Nov;23(9):3374-3386. Epub 2016 May 17.

PMID:
27128792
4.

Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.

Shelke S, Shahi S, Jalalpure S, Dhamecha D.

J Liposome Res. 2016 Dec;26(4):313-23. doi: 10.3109/08982104.2015.1132232. Epub 2016 Jan 12.

PMID:
26758957
5.

Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.

Alhalaweh A, Andersson S, Velaga SP.

Eur J Pharm Sci. 2009 Oct 8;38(3):206-14. doi: 10.1016/j.ejps.2009.07.003. Epub 2009 Jul 16.

PMID:
19616094
6.

Surface thermodynamics of mucoadhesive dry powder formulation of zolmitriptan.

Alhalaweh A, Vilinska A, Gavini E, Rassu G, Velaga SP.

AAPS PharmSciTech. 2011 Dec;12(4):1186-92. doi: 10.1208/s12249-011-9691-1. Epub 2011 Sep 15.

7.

Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.

Vyas TK, Babbar AK, Sharma RK, Misra A.

J Drug Target. 2005 Jun;13(5):317-24.

PMID:
16199375
8.

Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design.

Kumar A, Garg T, Sarma GS, Rath G, Goyal AK.

Eur J Pharm Sci. 2015 Apr 5;70:140-51. doi: 10.1016/j.ejps.2015.01.012. Epub 2015 Feb 10.

PMID:
25676136
9.

Formulation and evaluation of chitosan-chondroitin sulphate based nasal inserts for zolmitriptan.

Kaur K, Kaur G.

Biomed Res Int. 2013;2013:958465. doi: 10.1155/2013/958465. Epub 2013 Sep 24.

10.

Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.

Pitta SK, Dudhipala N, Narala A, Veerabrahma K.

Drug Dev Ind Pharm. 2018 Mar;44(3):484-492. doi: 10.1080/03639045.2017.1402918. Epub 2017 Nov 29.

PMID:
29124986
11.

Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.

Khan S, Patil K, Bobade N, Yeole P, Gaikwad R.

J Drug Target. 2010 Apr;18(3):223-34. doi: 10.3109/10611860903386938.

PMID:
20030503
12.

Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan.

Yu C, Gu P, Zhang W, Cai C, He H, Tang X.

Drug Deliv. 2011 Nov;18(8):578-85. doi: 10.3109/10717544.2011.600784. Epub 2011 Aug 12.

PMID:
21838542
13.

Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.

Gavini E, Rassu G, Sanna V, Cossu M, Giunchedi P.

J Pharm Pharmacol. 2005 Mar;57(3):287-94.

PMID:
15807983
14.

Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.

Gonçalves VSS, Matias AA, Poejo J, Serra AT, Duarte CMM.

Int J Pharm. 2016 Dec 30;515(1-2):1-10. doi: 10.1016/j.ijpharm.2016.09.086. Epub 2016 Oct 1.

PMID:
27702697
15.

Influence of chitosan glutamate on the in vivo intranasal absorption of rokitamycin from microspheres.

Gavini E, Rassu G, Ferraro L, Generosi A, Rau JV, Brunetti A, Giunchedi P, Dalpiaz A.

J Pharm Sci. 2011 Apr;100(4):1488-502. doi: 10.1002/jps.22382. Epub 2010 Oct 29.

PMID:
24081472
16.

Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.

Pandey P, Cabot PJ, Wallwork B, Panizza BJ, Parekh HS.

Eur J Pharm Sci. 2017 Jan 1;96:499-507. doi: 10.1016/j.ejps.2016.10.017. Epub 2016 Oct 19.

PMID:
27771516
17.

Rheological evaluation of thermoreversible and mucoadhesive nasal gels of Zolmitriptan.

Kumari A, Sharma N, Sharma PK, Goyal N.

Eur Rev Med Pharmacol Sci. 2012 Aug;16(8):1022-7.

PMID:
22913151
18.

Drug in Adhesive Patch of Zolmitriptan: Formulation and In vitro /In vivo Correlation.

Liu C, Fang L.

AAPS PharmSciTech. 2015 Dec;16(6):1245-53. doi: 10.1208/s12249-015-0303-3. Epub 2015 Mar 14.

19.

Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.

Bshara H, Osman R, Mansour S, El-Shamy Ael-H.

Carbohydr Polym. 2014 Jan;99:297-305. doi: 10.1016/j.carbpol.2013.08.027. Epub 2013 Aug 22.

PMID:
24274510
20.

Intranasal zolmitriptan.

Gawel M, Worthington I.

Expert Opin Pharmacother. 2005 Jun;6(6):1019-24. Review.

PMID:
15952929

Supplemental Content

Support Center